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A Strong Advocate for Laboratory Animal Medicine
by Susan I. Finkelstein

Over the course of his distinguished career,
Hilton J. Klein, V’80, has accomplished much
in the fields of critical research and human and
animal drug and vaccine discovery and development. During its Annual Convention in July
2003, the American Veterinary Medical Association recognized Klein’s contributions to the
field of laboratory animal science by honoring
him with the Charles River Prize, which is
awarded by the Charles River Foundation.
Currently the senior director of comparative medicine and director of the Department
of Laboratory Animal Resources for Merck
Research Laboratories in West Point, Pa., Klein
provides strategic planning and direction for
Merck’s animal care and use programs and is
the lead auditor for all animal care programs
for Merck worldwide. As Merck’s representative, Klein also played an important part in
establishing a conservation program for
neotropical primates in collaboration with the
Pan American Health Organization.
Klein credits his education at Penn’s
Veterinary School, with its emphasis on basic
science, for pointing him in the direction of a
research career. In fact, Klein notes, because of
Penn’s continued research-focused curriculum,
“Penn graduates are better equipped than ever
before to understand what’s going on in
research.” In 1977, as the very first Penn
student to participate in the Merck Summer
Research Fellowship Program, where he was
mentored by two laboratory animal veterinarians, Klein found his initial desire to practice
large animal medicine gradually giving way to
a growing interest in research.
After graduating from Penn in 1980, “an
opportunity to do research on human infectious diseases presented itself,” recalls Klein. As
manager of veterinary sciences at Whitaker
M.A. Bioproducts in Walkersville, Md., Klein,
in addition to his duties as clinical veterinarian
and laboratory animal care supervisor, helped
research and develop diagnostic tests for
infectious animal diseases, including ELISA
(Enzyme-Linked ImmunoSorbent Assay), a
fundamental tool of clinical immunology used
as an initial screen for HIV detection, and the
FA (Fluorescent Antibody) Test, which for
many years has been used to detect influenza
virus infection in frozen sections of lung. His
comparative infectious disease research

encompassed toxoplasmosis, herpes, and
cytomegalovirus.
In 1985, Klein joined Merck Research
Laboratories as a staff veterinarian, where he
collaborated with researchers in developing
animal models to establish “proof of concept”
and safety for human medicines and vaccines.
During his 18 years at Merck, the number of
animals has more than and the professional
staff tripled.
Klein was recently honored with Merck’s

2002 Animal Alternatives Award, along with
Thomas E. Nolan, D.V.M., recently retired from
Merck’s Department of Laboratory Animal
Resources. The award recognizes Merck
employees worldwide whose research and published work support the animal-alternatives
concept of “3 Rs”—replacing, reducing, or
refining animal models used in laboratory
research. Klein and Nolan’s award-winning
paper, “Methods in Vascular Infusion Biotechnology in Research with Rodents,” appeared in
2002 in the ILAR Journal, the publication of
the Institute for Laboratory Animal Research.
The paper describes innovative techniques
(with animal welfare in mind) that use miniaturized animal models to facilitate drug discovery and development. This novel technology is
now being used in Merck research areas—
including obesity, diabetes, cancer, and
vaccines—and will ultimately benefit both
human and animal health.
Because veterinarians trained to conduct
basic biomedical research are in short supply
across the country, many career opportunities

are available for veterinarians to enter the
research arena. Klein states, “We as
veterinarians shouldn’t consider research as an
‘alternative’ career; it’s a good primary career
that offers lots of opportunities for vets—in
agricultural research, biomedical research,
human medicine research—for which Penn
graduates are uniquely qualified.”
Research veterinarians can help shape animal welfare policies and practices at the local,
national, and global levels. Klein has worked
with international agencies like the World
Health Organization, regulatory agencies like
the United States Department of Agriculture,
accrediting agencies like the Association for
Assessment and Accreditation of Laboratory
Animal Care–International (where he served as
president of its Council on Accreditation), and
professional/scientific groups like ILAR. He has
traveled extensively throughout the world—
including places as diverse as Canada, Italy,
France, the Philippines, Taiwan, and Cuba,
where he actually met Fidel Castro. At each
stop, no matter how distant or unfamiliar, the
common thread was always animals and
research.
Klein points to the emerging field of “translational medicine” as another type of research
career available to graduates. Knowledge and
technology are being improved today at an
increasing pace—and with them, our desire to
see a rapid progression, or “translation,” of
information from laboratory to hospital, from
theoretical to practical. This desire generates
the need for a whole new range of trained professionals to perform the critical task of moving medical research closer to commercially
ready medical technology. Animals play an
integral part in the two main steps of this
“bench-to-bedside” research (first proving a
concept, and then ensuring its safety)—and
where there are laboratory animals, of course,
there is a need for veterinarians. “This is a
chance to help both humans and animals by
developing drugs and vaccines,” states Klein.
An adjunct associate professor of laboratory
animal medicine at Penn, the author or
coauthor of more than 30 scientific articles,
and a diplomate of the American College of
Laboratory Animal Medicine, Klein is uniquely
qualified to serve as an advocate for a field that
strives to advance the health and welfare of
humans and animals.
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